Lonza Adds Cytokines and Viral Production Medium to Cell Therapy Portfolio
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
One lab that participated in NILA's survey reports having enough reagent to process 500 tests per day, yet their covid-19 testing capacity is at least 3,000 tests per day.
The highly specific and high-affinity antibodies are suitable for bioanalytical and patient drug level monitoring assays for the immune checkpoint inhibitor ipilimumab.
The new brand will be rolled out throughout 2020 through the company’s website and marketing communications, as well as at each of its four locations.
Read MoreThe newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read MoreThe partners’ cartridge-based instrument offers a novel and disruptive analysis and monoclonality assurance system for drug discovery and development.
Read MoreBBI Solutions has announced the launch of new antibodies, including inflammatory, fertility, and infectious disease markers.
Read MoreThree new standardized, preformulated DuraClone RE kits deliver high sensitivity to help study rare cell populations.
Read MoreThe suite of reagents from Ortho Clinical Diagnostics is used to determine the status of a designated antigen on human red blood cells.
Read MoreViroStat has released a set of mouse monoclonal antibodies to E. histolytica.
Read MoreThis month’s issue features hematology, blood banking, and organ transplantation products from such companies as Abbott, Advanced Instruments, Helmer Scientific, and Ortho Clinical Diagnostics.
Read MoreInnova is providing custom magnetic beads and alkaline phosphatase conjugation services to support the conjugate screening phases of TTP’s assay development.
Read MoreBeckman Coulter Diagnostics, along with partner Diazyme Laboratories, has announced FDA premarket notification (510(k)) clearance of a new procalcitonin assay.
Read MoreAssays measure levels of adalimumab, infliximab, and vedolizumab and the antidrug antibodies.
Read MoreThe kit from Innova Biosciences allows users to covalently conjugate up to three capture and three detection antibodies with any antibody of their choice.
Read MoreThis month’s issue features products that will be featured at the American Association for Clinical Chemistry (AACC) meeting in San Diego.
Read MoreViroStat has released three new monoclonal antibodies to the Listeria species.
Read MoreThe consortium will work to qualify islet autoimmunity antibodies as prognostic biomarkers to be used in the development of therapies for the treatment and prevention of type 1 diabetes.
Read More